Fig. 6.

SUCRA for the cumulative probabilities.
Abbreviations: Placebo: 1, Belimumab: 2, Atacicept: 3, Epratuzumab: 4, Tabalumab: 5, Rituximab: 6, Blisibimod: 7

SUCRA for the cumulative probabilities.
Abbreviations: Placebo: 1, Belimumab: 2, Atacicept: 3, Epratuzumab: 4, Tabalumab: 5, Rituximab: 6, Blisibimod: 7